Yuval Tal, Yaarit Ribak, Limor Rubin, Aviv Talmon, Oded Shamriz, Alon Y Hershko, Simcha Blotnick, Mohammed Bouhajib, Galia Temtsin Krayz, Carolina Abrutzky, Dalia Megiddo, Tair Lapidot, Yoseph Caraco
BACKGROUND: Epinephrine intramuscular (IM) autoinjector is a life-saving drug for the emergency treatment of immediate-type allergic reactions (type I). Nevertheless, it is sometimes applied incorrectly or underused because of short shelf life, high costs, fear of use, or inconvenience of carrying. FMXIN002, a nasal powder spray of epinephrine, was developed as a needle-free alternative. OBJECTIVE: To compare epinephrine pharmacokinetics, pharmacodynamics, and safety after the administration of the FMXIN002 nasal spray versus autoinjector...
October 2023: Journal of Allergy and Clinical Immunology in Practice